Morocco Medical Cannabis Market Size, Share & Trends Analysis Report By Product (Flower, Oil & Tinctures), By Application (Chronic Pain, Tourette’s Syndrome, Cancer, Depression & Anxiety), And Segment Forecasts, 2023 - 2030

Market Size & Trends

The Morocco medical cannabis market size was valued at USD 24.90 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 48.0% from 2023 to 2030. The growth of the industry in the country is driven by several factors, including the increasing legalization of medical marijuana globally, the growing demand for alternative treatments for chronic diseases, and the country's longstanding reputation as a major producer of cannabis. In addition, the Moroccan government has undertaken steps to regulate and legalize its cultivation, which has encouraged investment and growth in the industry. 

Morocco is well known for its illegal marijuana production and has been a significant player in the global illicit marijuana market. However, with the recent legalization of medical cannabis in the country, there has been a growing interest in establishing a legal cannabis market. Morocco's reputation for cannabis has made it an attractive destination for tourists. According to High Times and South China Morning Post, Morocco is increasingly becoming a hotspot for marijuana tourism, with traditional hashish cafes, cannabis plantations, and markets being popular attractions. The country's cannabis industry has been estimated to be worth billions of dollars, and legalizing it for recreational use could bring in substantial tax revenue and create jobs.

The COVID-19 pandemic has possibly disrupted the production and distribution of medical cannabis in Morocco, but the specific impact on the industry remains unclear; the pandemic is said to have a mixed impact on this industry of the country. The pandemic has increased the demand for medical marijuana due to increased stress, anxiety, and other conditions.

However, the Moroccan government's measures to manage the pandemic, such as lockdowns and travel restrictions, indirectly affected the medical cannabis industry, making it difficult for patients to access products or producers to obtain necessary supplies. According to the International Drug Policy Consortium (IDPC), the pandemic has significantly impacted the cannabis market in Morocco. The global cannabis supply chain disruption has resulted in decreased demand and price drops for its products, directly impacting the livelihoods of Moroccan cannabis farmers.

Furthermore, the use of medical marijuana has quickly gained popularity in Morocco after its recent legalization. Treatment with medical marijuana benefits people suffering from chronic illnesses and pains associated with cancer, arthritis, Alzheimer's disease, Parkinson’s disease, depression, anxiety, and epilepsy. As a result, the widespread application of medical marijuana has contributed to its increased adoption for treating various chronic conditions.

Product Insights

Based on product, the market is segmented into flowers and oils & tinctures. The oils & tinctures segment held the majority of the revenue share of 51.3% in 2022 and is expected to grow at the fastest CAGR of 48.8% over the forecast period. The increasing number of patients requiring treatment for conditions such as epilepsy, PTSD, autism, chronic pain, muscle spasms resulting from multiple sclerosis, Parkinson's disease, and convulsions are expected to drive the demand for the oils & tinctures segment.

The oil & tincture segment is experiencing significant growth due to increasing consumer awareness of the health benefits of cannabis-derived products and the versatility they offer. Oils and tinctures provide convenient and discreet consumption methods, aligning with the growing demand for these products in domestic and international markets. Additionally, regulatory changes and the economic opportunities presented by the industry contribute to the expansion of the oil and tincture segment, positioning Morocco as a key player in this rapidly evolving market.

Application Insights

Based on application, chronic pain held the majority share of 27.3% in 2022. Its growth can be attributed to research indicating the beneficial effects of marijuana in mitigating pain and the significant incidence of chronic pain. Chronic pain is typically a symptom of multiple other medical conditions, such as neurogenic disorders; cancers; headaches; arthritis; and neck, lower back, & facial pain. This has significantly boosted the use of cannabis for pain relief, resulting in a larger market share.

The Tourette’s syndrome segment is expected to grow at a significant CAGR of 54.0% during the forecast period, owing to an increasing number of patients exploring the potential benefits of marijuana-based treatments. With the growing acceptance and legalization of medical marijuana, patients in Morocco are seeking alternative and complementary treatments, leading to a rise in demand for these products specifically tailored for managing Tourette's syndrome. The expanding availability of these products, along with the potential improvements in the quality of life they offer, make the Tourette's syndrome segment a significant focus within the market.

Key Companies & Market Share Insights

The market is in its initial phase of growth, and major market players are adopting various strategies such as acquisitions, partnerships, collaborations, expansions, and new product launches to strengthen their presence in the market. The use of marijuana products for treating chronic illnesses has become increasingly popular due to their various medical benefits, contributing to their growing market demand. In addition, major market players are implementing strategic measures, such as partnerships, mergers & acquisitions, collaborations, and new product launches, to expand their market shares.

Various other strategies are being adopted by players in the market to maintain their market position. For instance, in December 2022, PharmaCielo Ltd., a Canada-based cannabis company, announced the successful shipment of its first batch of pharmaceutical-grade cannabis extracts to a customer in Morocco. The company was one of the first to receive a license to export medical cannabis products to Morocco and is quickly emerging as a major player in the global cannabis market. Some prominent players in the Morocco medical cannabis market include:

• Bio Cannat

• PharmaCielo Ltd.

Morocco Medical Cannabis Market Report Scope

Morocco Medical Cannabis Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Morocco medical cannabis market report based on product, and application.

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Flower

  • Oil & Tinctures

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Cancer

  • Chronic Pain

  • Depression And Anxiety

  • Arthritis

  • Diabetes

  • Glaucoma

  • Migraines

  • Epilepsy

  • Multiple Sclerosis

  • AIDS

  • Amyotrophic Lateral Sclerosis

  • Alzheimer’s Disease

  • Post-traumatic Stress Disorder

  • Parkinson’s Disease

  • Tourette’s Syndrome

  • Others